Interim Results - 6 Months to 31 December 1999

McBride PLC 2 March 2000 McBride plc Interim results for the six months ended 31 December 1999 McBride is Europe's leading supplier of household and personal care retailer brand products and Europe's leading independent retailer brand and contract supplier of OTC pharmaceuticals Results highlights * A 5.9% increase in sales in local currency excluding the share of the joint venture * Operating profit of £17.8 million, before goodwill amortisation and share of the joint venture, increased by 7.2% from £16.6 million * Profit before taxation, goodwill amortisation and share of the joint venture increased by 8.5% to £15.3 million with strong growth from Continental Europe * Basic earnings per share were 6.4p compared with 6.0p, an increase of 6.7% * Interest cover was 7.1 times compared with 6.7 times * Interim dividend increased by 0.1p to 2.6p Strategic actions * The acquisition of Wrafton has taken McBride into the growth activity of OTC pharmaceuticals * Aerosol Products Limited, a joint venture with Nichol Beauty Products Limited, created the UK's largest manufacturer of retailer brand aerosols * The Eastern European business based in Poland performed strongly in the first half year Prospects * Expectations for the year remain in line with market projections. The trading environment is expected to be similar to the first half with McBride benefiting from new product developments, investment programmes and efficiency gains from the nearly completed rationalisation programme Commenting on the results, Mike Handley, Chief Executive said: 'The strategic direction of the Group is clear and further progress has been made in the first half of the year in difficult trading conditions. We expect the trading environment in the second half of the year to be similar but McBride will continue to benefit from new product developments, the effect of recent investment programmes and the efficiency gains from the nearly completed rationalisation programme.' For further information please contact: McBride plc 01494 607050 Mike Handley, Chief Executive Terry Monks, Group Finance Director Financial Dynamics 0171 831 3113 Andrew Dowler Interim review In the first six months of the financial year, McBride succeeded in growing both sales and profits compared with the first half of the previous year. Sales in local currency, excluding the sales of Aerosol Products Limited, the recently established joint venture, increased by 5.9% compared with the first half of last year. However, the continuing strength of the pound, principally against the Euro, resulted in sterling reported sales, including the share of the joint venture, being £247.4 million compared with £236.9 million in the first half of last year. Wrafton Laboratories, which was purchased in September 1999, contributed sales of £6.8 million in the period and is expected to be earnings enhancing in the financial year. Profits before goodwill amortisation and the contribution from Aerosol Products Limited increased to £17.8 million compared with £16.6 million in 1998/99. This growth reflected the continued improvement in most of the Continental European markets together with a growing contribution from Poland and the benefit of the Wrafton acquisition partly offset by the continuing difficult trading environment in the United Kingdom. Profit before taxation in the six months was £14.6 million compared with £14.0 million for the comparable period last year, an increase of 4.3%. The Board has declared an increased interim dividend of 2.6p per share compared with 2.5p which will be paid on the 18 May 2000 to shareholders on the register on 14 April 2000. United Kingdom Sales of household and personal care products in the United Kingdom were £128.9 million compared with £132.8 million in the first half of last year. The competitive activity in the UK market, which was noted in last year's review, persisted throughout the first six months of the current financial year and was the primary cause of the 2.9% decline in sales. During the first six months McBride successfully launched further variants of textile washing tablets which can be placed in either the drawer or the drum of the washing machine. These faster dissolving tablets have been successful and have gained an increased share of the tablet market, which has now grown to one fifth of the total textile washing market. The market for personal care products remained especially competitive in the period. The marketing initiatives of the branded manufacturers, together with the retailers' focus on price, combined to further reduce private label and minor brand shares. Operating profit in the UK, before goodwill amortisation and operating exceptional items, was £9.1 million and compared with £11.2 million in the first half of last year. Continental Europe Sales of household and personal care products in Continental Europe expressed in local currencies increased by 6.4% but the further strengthening of the pound resulted in sterling reported sales showing a marginal decline to £115.2 million compared with £115.6 million. The acquisitions made by McBride in France, the Netherlands and Poland in the last two years have strengthened the Group's position with the major European retailers. This, together with further growth in demand for private label and minor brand products, produced a good performance in the first half of the year. The level of demand in France was particularly strong showing sales growth of 11.2% over the first half of last year. Sales in Spain, Benelux and Poland also showed good progress and McBride opened its first sales office in Germany. Offices in the Czech Republic and Hungary will be opened in the second half of the year. In November there was a serious fire at the Estaimpuis factory which destroyed the raw material and packaging warehouse, together with the blow moulding department. However, management action successfully minimised the effect on both sales and customer service and the process of rebuilding the factory is progressing well with the full support and co-operation of the insurance companies. In Continental Europe, the operating profit before goodwill amortisation and exceptional items was £8.1 million, a 47.3% increase when compared with the first half of last year. Wrafton Laboratories In September 1999, McBride announced the acquisition of 80% of the share capital of Wrafton Laboratories for £17.3 million. This acquisition followed a strategic review of the opportunities for McBride to expand its product range, which identified the Over-The-Counter (OTC) medicines market as an important and growing market sector. The purchase of Wrafton is McBride's first strategic move outside the household and personal care sectors and will provide a base from which to build its business in the OTC medicines market. The UK market for OTC medicines is worth some £1.6 billion and is expected to continue to grow as the combination of higher NHS prescription charges and the increased awareness of the efficacy, safety and value of OTC pharmaceuticals is recognised by consumers. Wrafton operates in three main areas of the OTC market, namely oral analgesics, gastrointestinal and cold/flu remedies, all of which are experiencing solid growth. UK supermarkets have strategically grown their share of traditional chemist products with a major part of their product offering being the development of retailer brand alternatives. In the last two years the UK grocers have raised their share of the OTC market from 28% to 34% and within these sales retailer brand has increased from 18% to 21%. Prior to the acquisition by McBride, Wrafton had implemented a retailer brand development strategy alongside its long standing contract business. In the three months as part of McBride, the growth of retailer brand has accelerated although sales to contract customers have been adversely affected, in certain export markets, by the strength of sterling. Overall Wrafton has performed in line with expectations and will be earnings enhancing in the current financial year. Joint venture In October 1999 McBride announced the creation of a joint venture company with Nichol Beauty Products Limited. The joint venture, which is called Aerosol Products Limited, comprises the Hull site of Robert McBride together with the aerosol activities of Nichol Beauty Products. The closure of the Nichol site at Thetford is now substantially completed with almost all production having been moved into the Hull factory. The joint venture is now well established although the inevitable disruption during the process of rationalisation gave rise to customer service difficulties resulting in a trading loss in the period to the end of December of which the McBride share was £0.1 million before goodwill amortisation. Financial summary In the six months to the end of December 1999 net interest costs were £2.5 million which was the same as in the first half of the previous financial year. The level of interest expense reflected continued tight control of working capital together with the impact of marginally lower average interest rates and the impact of exchange rates in the translation of Euro denominated interest costs into sterling. Interest cover before goodwill amortisation was 7.1 times compared with 6.7 times in the first six months of last year. The charge for taxation has been calculated at 25% which is the same percentage rate as last year and represents the estimated effective rate for the current financial year. In the first six months of the financial year capital expenditure amounted to £9.5 million compared with £7.2 million last year. The main items of expenditure included the final phase of the extension of the Barrow textile washing powder factory, which is due to be commissioned in March 2000, additional equipment for the manufacture of textile washing tablets and completion of a further extension to the factory and warehouse in Poland. Cash flow from operating activities was £24.5 million compared with £18.2 million, with the increase of £6.3 million reflecting an improved operating profit together with better control of working capital. Net debt of £105.0 million at the end of December 1999 compared with £86.3 million at June 1999 and £90.0 million at December 1998. The increase of £18.7 million since June is less than the cost of purchasing Wrafton and the acquisition of the liquid products business of Nichol Beauty Products. An agreement with BP Amoco concerning the deferred consideration relating to the buy-in has resulted in a reduction in the provision for liabilities and charges of £9.0 million with the consequent reduction in goodwill and the increase in shareholder's funds. Equity shareholders funds at 31 December 1999 were £63.3 million compared with £50.9 million at June 1999 and £56.5 million at December 1998. Prospects Although the UK market for household and personal care products remains challenging, McBride continues to trade well from a strong market position. In Continental Europe, market conditions have improved which, together with the benefit of recent acquisitions, has given rise to the improved results. The purchase of Wrafton takes McBride into an important new market with considerable growth potential. The strategic direction of the Group is clear and further progress has been made in the first half of the year in difficult trading conditions. We expect the trading environment in the second half of the year to be similar but McBride will continue to benefit from new product developments, the effect of recent investment programmes and the efficiency gains from the nearly completed rationalisation programme. Lord Sheppard of Didgemere Mike Handley Chairman Chief Executive and Deputy Chairman Consolidated profit and loss account UK Before aerosol UK aerosol activities Unaudited activities before 6 months transfer to transfer to to 31 Dec J.V. J.V. 1999 Note £m £m £m Turnover: Group and share of joint venture 247.4 7.8 255.2 Less: share of joint venture's turnover (4.3) - (4.3) Group turnover (including acquisitions of £6.8 million) 1 243.1 7.8 250.9 Cost of sales (151.1) (5.8) (156.9) Gross profit/(loss) 92.0 2.0 94.0 Distribution costs (11.5) (0.2) (11.7) Administrative costs (63.2) (2.4) (65.6) Group operating profit/(loss) before goodwill amortisation (including acquisitions of £0.8 million) 1 17.8 (0.6) 17.2 Goodwill amortisation (0.5) - (0.5) Group operating profit/(loss) (including acquisitions of £0.6 million) 17.3 (0.6) 16.7 Share of joint venture's operating loss before goodwill amortisation (0.1) - (0.1) Goodwill amortisation on joint venture (0.1) - (0.1) Share of joint venture's operating loss (0.2) - (0.2) Goodwill previously written off to reserves - (1.4) (1.4) Loss on transfer of business to joint venture - (1.4) (1.4) Group interest receivable/ (payable) and similar charges (2.5) - (2.5) Profit/(loss) on ordinary activities before taxation 14.6 (3.4) 11.2 Tax on profit/(loss) on ordinary activities 2 (3.8) 0.1 (3.7) Profit/(loss) on ordinary activities after taxation 10.8 (3.3) 7.5 Equity minority interest (0.2) - (0.2) Profit/(loss) for the period 10.6 (3.3) 7.3 Dividends 4 (4.6) - (4.6) Retained profit/(loss) for the period 6.0 (3.3) 2.7 Earnings per ordinary share 3 * Basic and diluted 6.0p 4.1p * Basic before operating exceptional items, share of joint venture and goodwill amortisation 6.4p Before UK aerosol activities transfer to UK aerosol J.V. and activities operating before Operating exceptional transfer to exceptional items J.V. items £m £m £m Turnover: Group and share of joint venture 236.9 11.5 - Less: share of joint venture's turnover - - - Group turnover (including acquisitions of £6.8 million) 236.9 11.5 - Cost of sales (146.9) (7.9) (0.4) Gross profit/(loss) 90.0 3.6 (0.4) Distribution costs (11.0) (0.2) - Administrative costs (62.5) (3.3) (5.1) Group operating profit/(loss) before goodwill amortisation (including acquisitions of £0.8 million) 16.6 0.1 (5.5) Goodwill amortisation (0.1) - - Group operating profit/(loss) (including acquisitions of £0.6 million) 16.5 0.1 (5.5) Share of joint venture's operating loss before goodwill amortisation - - - Goodwill amortisation on joint venture - - - Share of joint venture's operating loss - - - Goodwill previously written off to reserves - Loss on transfer of business to joint venture - - - Group interest receivable/ (payable) and similar charges (2.5) - - Profit/(loss) on ordinary activities before taxation 14.0 0.1 (5.5) Tax on profit/(loss) on ordinary activities (3.5) - 0.1 Profit/(loss) on ordinary activities after taxation 10.5 0.1 (5.4) Equity minority interest - - - Profit/(loss) for the period 10.5 0.1 (5.4) Dividends (4.5) - - Retained profit/(loss) for the period 6.0 0.1 (5.4) Earnings per ordinary share * Basic and diluted 6.0p * Basic before operating exceptional items, share of joint venture and goodwill amortisation 6.0p All operations above are continuing Before Unaudited operating Operating Audited 6 months exceptional exceptional Year ended to 31 Dec items items 30 June 1998 1999 £m £m £m £m Turnover: Group and share of joint venture 248.4 496.8 - 496.8 Less: share of joint venture's turnover - - - - Group turnover (including acquisitions of £6.8 million) 248.4 496.8 - 496.8 Cost of sales (155.2) (307.8) (0.4) (308.2) Gross profit/(loss) 93.2 189.0 (0.4) 188.6 Distribution costs (11.2) (22.2) - (22.2) Administrative costs (70.9) (132.3) (11.3) (143.6) Group operating profit/(loss) before goodwill amortisation (including acquisitions of £0.8 million) 11.2 34.9 (11.7) 23.2 Goodwill amortisation (0.1) (0.4) - (0.4) Group operating profit/(loss) (including acquisitions of £0.6 million) 11.1 34.5 (11.7) 22.8 Share of joint venture's operating loss before goodwill amortisation - - - - Goodwill amortisation on joint venture - - - - Share of joint venture's operating loss - - - - Goodwill previously written off to reserves - - - - Loss on transfer of business to joint venture - - - - Group interest receivable/ (payable) and similar charges (2.5) (4.9) - (4.9) Profit/(loss) on ordinary activities before taxation 8.6 29.6 (11.7) 17.9 Tax on profit/(loss) on ordinary activities (3.4) (7.5) 1.2 (6.3) Profit/(loss) on ordinary activities after taxation 5.2 22.1 (10.5) 11.6 Equity minority interest - (0.1) - (0.1) Profit/(loss) for the period 5.2 22.0 (10.5) 11.5 Dividends (4.5) (13.4) - (13.4) Retained profit/(loss) for the period 0.7 8.6 (10.5) (1.9) Earnings per ordinary share * Basic and diluted 2.9p 12.4p 6.5p * Basic before operating exceptional items, share of joint venture and goodwill amortisation 12.7p Consolidated Balance sheet Unaudited Unaudited Audited 31 Dec 31 Dec 30 June 1999 1998 1999 Note £m £m £m Fixed assets Intangible assets 34.8 9.5 9.6 Tangible assets 146.7 145.2 147.7 Total fixed assets 181.5 154.7 157.3 Current assets Stocks 58.6 54.1 52.6 Debtors 93.3 97.5 93.1 Cash at bank and in hand 1.0 5.6 4.7 152.9 157.2 150.4 Creditors: amounts falling due within one year (160.3) (152.6) (150.2) Net current assets/(liabilities) (7.4) 4.6 0.2 Total assets less current liabilities 174.1 159.3 157.5 Creditors: amounts falling due after more than one year (104.4) (92.4) (90.2) Provisions for liabilities and charges (2.9) (10.3) (16.3) Investments in joint ventures Share of gross assets 13.1 - - Share of gross liabilities (15.5) - - Net investment in joint venture (2.4) - - Net assets 64.4 56.6 51.0 Capital and reserves Called up share capital 17.8 17.8 17.8 Share premium account 139.3 139.3 139.3 Profit and loss account 5 (93.8) (100.6) (106.2) Equity shareholders' funds 63.3 56.5 50.9 Equity minority interest 1.1 0.1 0.1 Net assets 64.4 56.6 51.0 Consolidated cash flow statement Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 Note £m £m £m Cash flow from operating activities 6 24.5 18.2 48.2 Returns on investments and servicing of finance (2.3) (2.6) (5.1) Taxation (0.5) (0.9) (6.8) Operating cash flow after taxation and finance costs 21.7 14.7 36.3 Capital expenditure (9.5) (7.2) (19.2) Acquisitions (22.7) (16.4) (22.5) Equity dividend paid (8.9) (8.8) (13.2) Financing 15.7 14.6 14.8 Decrease in cash in the period (3.7) (3.1) (3.8) Reconciliation of net cash flow to movement in net debt Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 £m £m £m Decrease in cash in the period (3.7) (3.1) (3.8) Cash outflow from movement in debt and lease financing (15.7) (14.6) (14.7) Change in net debt resulting from cash flows (19.4) (17.7) (18.5) Loans and finance leases acquired with subsidiary (2.6) (1.5) (1.5) Translation differences 3.3 (4.4) 0.1 Movement in net debt in the period (18.7) (23.6) (19.9) Net debt at the beginning of the period (86.3) (66.4) (66.4) Net debt at the end of the period (105.0) (90.0) (86.3) Statement of total recognised gains and losses Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 £m £m £m Profit after tax 7.3 5.2 11.5 Unrealised foreign currency differences (0.7) 2.0 0.5 Total recognised gains and losses 6.6 7.2 12.0 Reconciliation of movements in total shareholders' funds Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 £m £m £m Opening shareholders' funds 50.9 51.0 51.0 Profit for the financial period 7.3 5.2 11.5 Equity dividends (4.6) (4.5) (13.4) 53.6 51.7 49.1 Unrealised foreign currency differences (0.7) 2.0 0.5 New share capital subscribed (including merger reserve) - 2.8 2.8 Goodwill written back/(off) to profit and loss account 10.4 - (1.5) Closing shareholders' funds 63.3 56.5 50.9 Notes to the interim financial statements 1. Segmental information Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 £m £m £m Turnover by destination is analysed by geographical area as follows: UK 131.9 130.9 258.1 Continental Europe 116.6 116.0 232.9 Rest of World 2.4 1.5 5.8 250.9 248.4 496.8 Turnover by geographical origin is analysed as follows: UK 135.7 132.8 265.1 Continental Europe 115.2 115.6 231.7 250.9 248.4 496.8 Turnover by class of business is analysed as follows: Household products 203.0 200.6 406.1 Personal care products 41.1 47.8 90.7 Pharmaceuticals 6.8 - - 250.9 248.4 496.8 Operating profit by geographical origin is analysed as follows: UK 8.7 8.2 18.6 Continental Europe 8.0 2.9 4.2 Operating profit 16.7 11.1 22.8 Share of joint venture after goodwill (0.2) - - Goodwill previously written off to reserves (1.4) - - Loss on transfer of business to joint venture (1.4) - - Net interest payable (2.5) (2.5) (4.9) Profit on ordinary activities before tax 11.2 8.6 17.9 Operating profit by class of business is analysed as follows: Household products 15.1 13.7 27.2 Personal care products 1.0 (2.6) (4.4) Pharmaceuticals 0.6 - - Operating profit 16.7 11.1 22.8 Share of joint venture after goodwill (0.2) - - Goodwill previously written off to (1.4) - - reserves Loss on transfer of business to joint (1.4) - - venture Net interest payable (2.5) (2.5) (4.9) Profit on ordinary activities before tax 11.2 8.6 17.9 2. Tax on profit on ordinary activities The Group tax charge is calculated at 25% of the profit before taxation excluding non taxable deductions, being the estimated effective rate of tax for the year to 30 June 2000. 3. Earnings per ordinary share Earnings per ordinary share is calculated on profit after tax in accordance with FRS 14. The calculation of earnings per ordinary share for the six months ended 31 December 1999 is based on 177,639,197 ordinary shares of 10p each, which was the number of ordinary shares in issue at 30 June 1999 and 31 December 1999. The weighted average number of shares in issue at 31 December 1998 and 30 June 1999 was 176,178,267 and 176,869,413 respectively. 4. Dividend The Directors will pay an interim dividend of 2.6p per ordinary share on 18 May 2000 to shareholders registered at the close of business on 14 April 2000. 5. Profit and loss account Unaudited Unaudited Audited 31 Dec 31 Dec 30 June 1999 1998 1999 £m £m £m Goodwill reserve (146.4) (155.3) (156.8) Profit and loss account 52.6 54.7 50.6 (93.8) (100.6) (106.2) 6. Reconciliation of operating profit to operating cash flow Unaudited Unaudited Audited 6 months 6 months Year ended to 31 Dec to 31 Dec 30 June 1999 1998 1999 £m £m £m Group operating profit 16.7 11.1 22.8 Depreciation 8.8 8.3 16.9 Other non cash items - 5.5 9.9 Goodwill amortisation 0.5 0.1 0.4 Movement in stocks (7.8) 4.0 4.0 Movement in debtors (2.1) (4.7) (0.2) Movement in creditors 8.4 (6.1) (5.6) Cash flow from operating activities 24.5 18.2 48.2 7. Unaudited half year results The results for the half year ended 31 December 1999 and 31 December 1998 are unaudited and have been prepared on the basis of accounting policies set out in the Report and Accounts for the year ended 30 June 1999. The comparative figures for the year ended 30 June 1999 do not constitute statutory accounts. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors thereon was unqualified and did not contain a statement under Section 237(2) or (3) of the Companies Act 1985. The Group has implemented FRS 15 - Tangible fixed assets in preparing these financial statements. Financial calendar for the year ending 30 June 2000 Dividends Interim Announcement 2 March 2000 Payment 18 May 2000 Final Announcement September 2000 Payment November 2000 Results Interim Announcement 2 March 2000 Preliminary statement for full year Announcement September 2000 Report and Accounts Circulated September 2000 Annual General Meeting To be held October 2000

Companies

Mcbride (MCB)
UK 100

Latest directors dealings